Search results
Royal Bank of Canada Increases Moderna (NASDAQ:MRNA) Price Target to $135.00
ETF DAILY NEWS· 11 hours agoModerna (NASDAQ:MRNA – Get Free Report) had its target price lifted by Royal Bank of Canada from $125.00 to $135.00 in a report issued on Friday, Benzinga reports. Royal Bank ...
Mission Wealth Management LP Acquires New Holdings in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 10 hours agoMission Wealth Management LP bought a new position in Moderna, Inc. (NASDAQ:MRNA – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities ...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 3 days agoIn the first quarter of the year, Moderna reported $167 million in sales of its only product on the...
Moderna ends gene editing alliance with Metagenomi
BioPharma Dive via Yahoo Finance· 3 days agoMetagenomi said the companies’ decision to part ways followed a “strategic prioritization” undertaken by Moderna, which has made several investments in...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 3 days agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 3 days agoModerna (MRNA) beat Wall Street's first-quarter expectations Thursday. The Covid vaccine maker came...
Moderna makes several cost-cutting moves, leans into AI - Boston Business Journal
The Business Journals· 3 days agoModerna and Metagenomi framed the news as a mutual decision, and Moderna said it “continues to...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 3 days agoOne analyst called the results "transformational." And Moderna stock surged more than 9% on Dec. 19,...
Moderna Stock Takes Minimal Hit After New COVID Vaccine Topped Projected Estimates
Black Enterprise· 2 days agoModerna announced an increase in stock price after their COVID vaccine exceeded sales estimates for...
Moderna to seek parity for RSV shot (NASDAQ:MRNA)
Seeking Alpha· 3 days agoModerna (MRNA) stock gains as the company highlights its upcoming RSV shot, expecting the U.S. regulators to endorse it on par with rival products. Read more here.